Generic Timolol Maleate Ophthalmic Gel-Forming Solution from Mexico
Gel-forming ophthalmic solution with timolol maleate for once-daily glaucoma treatment, in retail multi-dose bottles. It qualifies for HTS 3004.90.92.72 as an eye-affecting medicament in measured doses containing timolol maleate, distinct from standard drops. The gel matrix provides prolonged release for therapeutic efficacy.
Duty Rate — Mexico → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Ensure gel formulation stability testing reports are available for CBP review during ophthalmic import clearance
• Comply with USP standards for sterility and include batch certificates to expedite FDA admission
• Watch for misclassification pitfalls by specifying 'measured dose retail packing' in entry documentation